Login / Signup

Antibody responses following the surge of SARS-CoV-2 Omicron infection among patients with systemic autoimmune rheumatic diseases.

Nan XiangYu-Jing LiMeng-Yao LiuQi-Qin WuYa-Xin ZhangHui-Zhi JinQian WangYu-Wei LiDa-Li TongTian XueTeng-Chuan JinWei BaoZhu Chen
Published in: Rheumatology advances in practice (2023)
These data suggest that patients with SARDs had a lower antibody response than HCs after Omicron infection.
Keyphrases
  • sars cov
  • multiple sclerosis
  • electronic health record
  • respiratory syndrome coronavirus
  • big data
  • drug induced
  • machine learning
  • coronavirus disease